Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110028448B details a cost-effective copper-catalyzed synthesis of 3-hydroxy-2,3-dihydroisoquinoline-1,4-dione intermediates, offering significant supply chain advantages.
Novel patent CN115403505B enables efficient thioester synthesis using sulfonyl chloride. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel Pd-catalyzed one-pot method for high-purity intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN115215810B reveals catalyst-free synthesis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global buyers.
Novel patent CN104045592A details mild synthesis of 5-fluoroindole-2-one. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102603624A reveals a scalable Pd-catalyzed route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN112250614B details a metal-free, one-pot synthesis of 3-spiro-tricyclic indolones using NBS, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel Pd-catalyzed route for chroman amides using nitroarenes. Reduces cost and complexity in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN108033866B details a green Ru-catalyzed cyclization for naphthalene derivatives, offering cost reduction in optoelectronic material manufacturing and high-purity pharmaceutical intermediates.
Patent CN107641068A reveals a palladium-catalyzed route for indanone derivatives offering significant supply chain stability and reduced environmental waste for manufacturers.
Patent CN107501267B reveals Pd-catalyzed asymmetric allylic amination for high-purity nucleoside intermediates. Enables cost reduction and supply chain reliability.
Patent CN113354573A reveals a scalable route for alpha,alpha-terpyridine. Eliminate palladium residues and achieve 99.4% purity for optical and pharma applications.
Patent CN112939780A details a Rh-catalyzed C-H activation route for indanone derivatives, offering high yields and functional group tolerance for reliable pharmaceutical intermediate supply.
Novel nickel-catalyzed route for tetralone skeletons offering high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation route for quinolinone derivatives offering high yields and simplified purification for pharmaceutical intermediates.
Novel cyclization route for spiro-piperidine intermediates offering high yield and scalability for pharmaceutical manufacturing.
Patent CN113735777B reveals a metal-free route for cyclic thiourea compounds. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN115353511A details a safe, multicomponent synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering cost-effective pharmaceutical intermediate manufacturing.
Novel iron-catalyzed C-H/N-H activation route for pyrrolo[1,2-a]indole derivatives. Offers mild conditions, high yields, and cost-effective scalability for API manufacturing.
Patent CN115353511A details a safe, multi-component Pd-catalyzed carbonylation route for indolinone-imidazole derivatives, offering significant supply chain advantages.